Yu-chen Han
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Combined type A thymoma and yolk sac tumour of the mediastinum.
Journal: Pathology
Published: December 03, 2023
Who benefit from adjuvant chemotherapy in stage I lung adenocarcinoma? A multi-dimensional model for candidate selection.
Journal: Neoplasia (New York, N.Y.)
Published: November 09, 2023
Extracting laboratory test information from paper-based reports.
Journal: BMC medical informatics and decision making
Published: October 25, 2022
Treatment of stage III non-small cell lung cancer in the era of immunotherapy: pathological complete response to neoadjuvant pembrolizumab and chemotherapy.
Journal: Translational lung cancer research
Published: November 19, 2020
EGFR Thr790Leu as a Potential Resistance Mechanism to First-Generation EGFR Tyrosine Kinase Inhibitor May Respond to Osimertinib in Patients With Lung Adenocarcinoma.
Journal: JTO clinical and research reports
Published: November 02, 2020
Lamin B2 promotes the malignant phenotype of non-small cell lung cancer cells by upregulating dimethylation of histone 3 lysine 9.
Journal: Experimental cell research
Published: February 10, 2020
Primary lung mucosa-associated lymphoid tissue lymphoma accompanied by multiple sclerosis: case report and molecular diagnosis.
Journal: Chinese medical journal
Published: July 06, 2019
ANKHD1 promotes proliferation and invasion of non‑small‑cell lung cancer cells via regulating YAP oncoprotein expression and inactivating the Hippo pathway.
Journal: International journal of oncology
Published: March 21, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026